Figure 4From: Cost-effectiveness of abatacept, rituximab, and TNFi treatment after previous failure with TNFi treatment in rheumatoid arthritis: a pragmatic multi-centre randomised trialMean quality-adjusted life-years and medication-related costs in a 1-year period. Error bars represent the upper bars of the 95% confidence intervals. QALY, Quality-adjusted life-year.Back to article page